FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs

Health Wall Street Journal review finds agency oversteps trials to protect patients, ensures studies are properly…

FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease

The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…